comparemela.com

Latest Breaking News On - Pharma stocks - Page 10 : comparemela.com

DRL shares: Stock Radar: 89-DMA crucial support for Dr Reddy's Laboratories; likely to head towards Rs 6,000

“Dr Reddy’s Laboratories has been in a corrective phase in the last couple of months, but this entire down move just seems to be a corrective phase within an uptrend,” Ruchit Jain, Lead Research, 5paisa.com, said.

Days-exponential-moving-average
Stocks-to-buy
Stock-radar
Stock-ideas
Pharma-stocks
Drl-shares
Drl-share-prices
Dr-reddy-rsquos-shares
Dr-reddy-rsquos-laboratories

stock analysis: Stock Radar: Pharma stocks in focus! Cipla could retest record highs in short term

Short-term traders can buy the stock for a possible short-covering move which could take the stock towards 1275 levels, suggest experts. The stock reversed losses after hitting a low of Rs 852 on 22 March 2023. The stock closed at Rs 1223 on 19 October which translates into an upside of over 40%.

Cipla-ltd
Days-exponential-moving-average
Technical-analysis
Stock-radar
Stock-market
Stock-analysis
Short-term-traders
Shivangi-sarda
Record-highs
Pharma-stocks
Motilal-oswal-financial-services-ltd

upside potential: Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%

There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising interest rates and other economic headwinds have little impact on their working because they are taking care of a need which is very basic in nature and if spending has to be done on that, it cannot be postponed. Pharmaceutical companies come into that category. This is not to say that there was a phase of almost 7 years that pharma stocks became under-performers. That was a very different reason, most of which have been taken care of. So there is a good chance that this time pharma stock will be able to tackle bears in a much better way.

Market-research
Google
Unlimited-access
Economic-times
Saver-sale
Membershipclaim-offer
Prime-story
Debit-cards
Includes-docubay
Economic-times-stories
Industry-trends

Geopolitical Tensions Continue To Cast Their Shadow Nifty Sensex Close On Red - BW Businessworld

Nifty 50 index closed down 0.71 per cent at 19,671 points, while Sensex lost 0.83 per cent including ten other indices traded in red, , stock market, nifty, sensex, Intraday, investment, pharma stocks, PSU Bank, losses to investors, IPO launch, cipla, dr reddy, oil stocks, icici prudential, biocon

Malaysia
Israel
Hindustan
India-general
India
Bharat
Mandar-bhojane
Shrikant-chouhan
Bajaj-finserv
Head-of-research-retail
Nifty-energy
Wipro

pharma stocks to buy: Second & better attempt; 5 Indian pharma stocks with upside potential of up to 31%

Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performance was due to over valuation at which these companies were trading since 2015. Also stocks came in the overowned category for both the institutional and retail investors portfolio. Last but not the least, close to 2014, USFDA inspections became both more in numbers and stricter, many companies which assumed that they can take care of anything, got a rude shock. After all the head and tailwinds, many companies which had changed their focus, fruits are visible in terms of them moving into new markets and better financials.

India
China
Market-research
Google
Unlimited-access
Economic-times
Saver-sale
Membershipclaim-offer
Prime-story
Debit-cards
Includes-docubay

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.